Prothena Corporation plc Announces the Appointment of Hideki Garren, MD, PhD, as Chief Medical Officer

Chartwell is delighted to have served as executive search partner to Prothena for the Company’s recruitment of its Chief Medical Officer, Hideki Garren, MD, PhD. The breadth and success of Dr. Garren’s neuroscience drug development experience will be distinct advantages as Prothena looks towards the continued development, registration, and commercialization of its first assets. Most recently, Dr. Garren served as Global Head of the Neuroimmunology franchise for Roche/Genentech. He began his career in an entrepreneurial setting, spinning out technology he co-invented while at Stanford University to form Bayhill Therapeutics where Dr. Garren served as EVP, Chief Scientific Officer and Chief Operating Officer.

For additional information regarding this appointment, please visit: https://ir.prothena.com/news-releases/news-release-details/prothena-announces-appointment-hideki-garren-md-phd-chief